You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adult erythroleukemia (M6a)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +15 more
  • trebananib
  • +3 more
  • Buffalo, New York
  • +1 more
Sep 8, 2022

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) Trial

Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +13 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Feb 2, 2023

Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7) Trial in Atlanta,

Terminated
  • Adult Acute Basophilic Leukemia
  • +16 more
  • eltrombopag olamine
  • standard follow-up care
  • Atlanta, Georgia
  • +1 more
Jul 20, 2022

Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Basophilic Leukemia, Adult

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
  • +18 more
  • eltrombopag olamine
  • Cleveland, Ohio
    Case Comprehensive Cancer Center
Nov 29, 2021

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Terminated
Has Results
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +15 more
  • fludarabine phosphate
  • +4 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Aug 20, 2021

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Completed
Has Results
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +16 more
  • choline magnesium trisalicylate
  • +3 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Aug 20, 2021

Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7) Trial in United

Completed
Has Results
  • Adult Acute Basophilic Leukemia
  • +16 more
  • Little Rock, Arkansas
  • +53 more
Jan 13, 2022

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +16 more
  • standard follow-up care
  • +2 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Jul 29, 2020

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) Trial

Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +16 more
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
May 13, 2020

Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia

Completed
Has Results
  • Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
  • +16 more
  • nonmyeloablative allogeneic hematopoietic stem cell transplantation
  • +5 more
  • Portland, Oregon
  • +1 more
Jan 15, 2020

Healthy Volunteers Trial in Toronto (Obicetrapib, Atorvastatin Calcium, Rosuvastatin Calcium)

Not yet recruiting
  • Healthy Volunteers
  • Toronto, Ontario, Canada
    Mark M Feldman
Oct 10, 2023

The Role of m6A RNA Modification in Moyamoya Disease

Recruiting
  • Moyamoya Disease
    • Beijing, Beijing, China
      Beijing Tiantan Hospital Capital Medical University
    Feb 16, 2022

    National Survey of Young Adult Nutrition

    Recruiting
    • Overweight or Obesity
    • Study participants
    • Grand Forks, North Dakota
      USDA Grand Forks Human Nutrition Research Center
    Oct 17, 2023

    Learning Disability Group Art Therapy: Looking and Asking

    Recruiting
    • Learning Disability, Adult
    • +3 more
    • Ethnographically-informed group observation
    • +2 more
    • Salford, Manchester, United Kingdom
    • +1 more
    Feb 27, 2023

    Disease Activity in Canadian Adult Moderate-to-Severe Atopic

    Recruiting
    • Atopic Dermatitis
      • Calgary, Alberta, Canada
      • +17 more
      Jan 17, 2023

      Allergic Rhinitis Trial in Toronto (AllerPops)

      Completed
      • Allergic Rhinitis
      • AllerPops
      • Toronto, Ontario, Canada
        Dicentra
      Jul 20, 2023

      Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Houston (6 Minute Walk Functional Test, Behavioral

      Recruiting
      • Hematopoietic and Lymphoid Cell Neoplasm
      • Malignant Solid Neoplasm
      • 6 Minute Walk Functional Test
      • +3 more
      • Houston, Texas
      • +1 more
      Jan 6, 2023

      Hereditary Transthyretin Amyloidosis With Polyneuropthy Trial in Canada, United States (Blood samples for immunoglobulins, Blood

      Recruiting
      • Hereditary Transthyretin Amyloidosis With Polyneuropthy
      • Blood samples for immunoglobulins
      • +2 more
      • Rosedale, New York
      • +3 more
      Dec 19, 2022

      Study of a Deformability Parameter of Red Blood Cell

      Not yet recruiting
      • Drepanocytosis
      • basal blood collection
      • +2 more
      • (no location specified)
      May 10, 2023

      Hypertension, Diabetes, Type 2 Trial in Incheon (BR1019-1, BR1019-2, BR1019-1 + BR1019-2)

      Recruiting
      • Hypertension
      • Diabetes Mellitus, Type 2
      • Incheon, Korea, Republic of
        Inha University Hospital
      May 16, 2023

      Type 1 Diabetes Trial in Canada, Sweden, United States (MiniMed 780G System)

      Recruiting
      • Type 1 Diabetes
      • MiniMed 780G System
      • Little Rock, Arkansas
      • +14 more
      Jan 20, 2023

      Solid Tumors, Adult Trial in Dallas, Hangzhou (HF158K1 /Arm 2 mg/m², HF158K1 /Arm 6 mg/m², HF158K1 /Arm 15 mg/m²)

      Not yet recruiting
      • Solid Tumors, Adult
      • HF158K1 /Arm 2 mg/m²
      • +5 more
      • Dallas, Texas
      • +2 more
      May 6, 2023

      Type 1 Diabetes Trial in Canada, United States (Insulin glargine, 300 units per milliliter (U/mL), Background therapy: Rapid

      Terminated
      Has Results
      • Type 1 Diabetes Mellitus
      • Insulin glargine, 300 units per milliliter (U/mL)
      • Background therapy: Rapid Acting meal time insulin analogs (Humalog, Novolog or Apidra)
      • West Des Moines, Iowa
      • +5 more
      Mar 24, 2022

      Oral Upadacitinib Tablets to Assess Change in Disease Symptoms

      Recruiting
      • Rheumatoid Arthritis (RA)
        • Edmonton, Alberta, Canada
        • +38 more
        Jan 17, 2023

        Gaucher Disease Type 1, Gaucher Disease Type 3 Trial in Worldwide (venglustat (GZ402671), imiglucerase)

        Active, not recruiting
        • Gaucher Disease Type 1
        • Gaucher Disease Type 3
        • New Haven, Connecticut
        • +6 more
        Aug 9, 2022